A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML
- Submitting institution
-
Cardiff University / Prifysgol Caerdydd
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 95827512
- Type
- D - Journal article
- DOI
-
10.1182/blood-2016-07-730648
- Title of journal
- Blood
- Article number
- -
- First page
- 1143
- Volume
- 129
- Issue
- 9
- ISSN
- 0006-4971
- Open access status
- Compliant
- Month of publication
- November
- Year of publication
- 2016
- URL
-
http://dx.doi.org/10.1182/blood-2016-07-730648
- Supplementary information
-
https://ash.silverchair-cdn.com/ash/content_public/journal/blood/129/9/10.1182_blood-2016-07-730648/5/blood-2016-07-730648-1.pdf?Expires=1612706678&Signature=clvy4URKYuYxFn6Ba7tgqedN4~7ANgl1Zca39cu0bVnbVWJYsxPGtrOUHs5kkBsRWzBqzyfuBYGlViCY~8eopNGo~Fp9EkA74pz-w3gIbSoSRVAabgtrjOUrliwnuo0kHLORBr5h1Xayt~5Tql5iLq3MMtfIosbTY4fjJ6iO1AYpEow5xk~ft6o7whTMzoaNEokE6zUsVjuB1NY73HKayBsOZgTlnp0m8rYdwYslEzJT7O6yc71BR6Xo5~k81bSZSIiHWSs3WH-7vZ1PzZUtlz-oHXFLMZM6oKTjmdA4C-6xj7yeqScX69LDprRPWzcx6cOca-vVrIuGQSQYQU5ItA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
12
- Research group(s)
-
-
- Citation count
- 83
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
-
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
